Advancing Infectious Disease Detection and Response in Senegal
The summary for the Advancing Infectious Disease Detection and Response in Senegal grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.
Advancing Infectious Disease Detection and Response in Senegal: The purpose of this Notice of Funding Opportunity (NOFO) is to conduct public health research projects (using quantitative, qualitative, and /or mixed methods), epidemiological studies, clinical, and laboratory-based projects, and surveillance of important diseases in Senegal. These public health research projects could include but not limited to activities to address acute febrile illness, antimicrobial resistance and hospital acquired infections, respiratory infections and influenza, enteric illnesses, and other public health threats. Other areas for research include emerging and re-emerging infectious diseases, zoonotic and vector borne diseases; environmental health issues effecting infectious diseases (such as water and air); vaccine-preventable diseases; biosafety and security; public health threats of local importance, and implementation research to evaluate the impact of public health programs and interventions and their cost effectiveness.
Federal Grant Title: | Advancing Infectious Disease Detection and Response in Senegal |
Federal Agency Name: | Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-GH-19-003 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.326 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | February 21st, 2019 |
Original Application Deadline: | February 21st, 2019 |
Posted Date: | December 21st, 2018 |
Creation Date: | December 21st, 2018 |
Archive Date: | March 23rd, 2019 |
Total Program Funding: | $5,000,000 |
Maximum Federal Grant Award: | $1,000,000 |
Minimum Federal Grant Award: | $0 |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
Last Updated: | December 21st, 2018 |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Single source competition. Only the application from Institute Pasteur Dakar will be accepted.
- Grant Announcement Contact
- Lata Kumar
[email protected]
Grants Policy - Similar Government Grants
- • Advancing Public Health Research in Bangladesh
- • Conducting Public Health Research with Universities in Thailand
- • Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and...
- • Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and...
- • Conducting Public Health Research in Thailand: Technical collaboration with the Ministry o...
- • Conducting Public Health Research in Kenya
- • Conducting Public Health Research in Thailand: technical collaboration with the Ministry o...
- • Institutional Research Collaboration between the Liverpool School of Tropical Medicine and...
- More Grants from the Centers for Disease Control and Prevention ERA
- • Collaborative research on influenza and other respiratory pathogens in South Africa
- • Advancing Public Health Research in Bangladesh
- • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...
- • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...
- • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...